Purchase Order 15B20526P00000151

<p>Federal Medical Center Devens awarded a purchase order to Priority Healthcare Distribution Inc. for $23,427.66 on July 1, 2026, for Uptravi 1000 MCG tablets (selexipag), a cardiovascular agent used in pulmonary arterial hypertension treatment. Performance occurs in Lake Mary, Florida, with a completion date of July 31, 2026. The order is firm fixed price with no set-aside designation.</p>

<p>Federal Medical Center Devens awarded a purchase order to Priority Healthcare Distribution Inc. (operating as Curascript SD Specialty Distribution) for $23,427.66 on April 1, 2026, for Uptravi 1000 mcg tablets, a cardiovascular agent used to treat pulmonary arterial hypertension. Performance occurs in Lake Mary, Florida, with an ultimate completion date of April 30, 2026. The order carries firm fixed-price pricing and no set-aside designation.</p>

Federal Medical Center Devens awarded a purchase order to Priority Healthcare Distribution Inc., operating as Curascript SD Specialty Distribution, for $23,427.66 on May 18, 2026. The order is for Uptravi 1200 MCG tablets (selexipag), a cardiovascular agent used to treat pulmonary arterial hypertension, procured under firm fixed-price pricing with lowest-price technically acceptable evaluation. No small business set-aside applies. Performance is to occur in Lake Mary, Florida, with an ultimate...

Priority Healthcare Distribution Inc., operating through its division Curascript SD Specialty Distribution, was awarded a $29,248.50 firm fixed-price purchase order by the Federal Medical Center Devens on August 28, 2025, for the supply of Selexipag 200 microgram tablets (trade name Uptravi). This cardiovascular medication is used primarily in the treatment of pulmonary arterial hypertension. The contract, which carries no small business set-aside designation, is scheduled for completion by...

The Department of Defense awarded a firm fixed price purchase order to Priority Healthcare Distribution Inc., doing business as Curascript SD Specialty Distribution, for the supply of Uptravi 800 microgram tablets (National Drug Code 66215-0608-06), a cardiovascular agent used in the treatment of pulmonary arterial hypertension. The contract, awarded on December 10, 2025, carries a ceiling value of $22,743.10 and is scheduled for completion by December 10, 2025. The award was made on a lowest...

The Federal Correctional Institution Fort Worth issued a $46,855.32 delivery order to Actelion Pharmaceuticals US, Inc., on August 1, 2026, for pharmaceutical supplies under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order calls against the GSA FSS-61-IB schedule, a $438.2 million indefinite delivery vehicle awarded August 1, 2024, and running through July 31, 2044. The order covers Uptravi (selexipag) and Opsumit (ambrisentan) with ultimate completion on August...

This is a federal contract award to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20. The contract is for the delivery of the drug Selexipag (Uptravi), a treatment for pulmonary arterial hypertension. The contract has a ceiling value of $70,629.56 and is a firm-fixed-price delivery order with an ultimate completion date of August 7, 2025. The contract is not set aside for small businesses....

This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 16 to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical drug Uptravi-Selexipag. The $144,743.29 contract has a completion date of March 17, 2022 and supports the VHA's distribution of critical medications to treat pulmonary arterial hypertension for patients and...

The Federal Medical Center Devens issued a $150,000 delivery order to University of Massachusetts Medical School on August 1, 2026, for comprehensive outpatient institution services at FMC Devens, MA. The order is issued under IDC 15B20521D00000001, which supports outpatient institution and transplant services at FMC Devens and carries a portfolio of 159 task orders valued at $68.4 million combined potential value. The order covers the period through August 31, 2026. Place of performance is...

The Defense Logistics Agency awarded a $72,201.78 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of UPTRAVI 800 microgram tablets (60 count). Issued on September 26, 2025, with an ultimate completion date of October 20, 2025, this firm fixed-price delivery order carries no set-aside designation. The order represents a discrete task issued under DMS Pharmaceutical Group's larger Indefinite...